GEA
AXNX

Glen Eagle Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Glen Eagle Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50
Closed -$3.48K – 1170
2024
Q3 		$3.48K Hold
50
– – ﹤0.01% 827
2024
Q2 		$3.36K Hold
50
– – ﹤0.01% 822
2024
Q1 		$3.45K Hold
50
– – ﹤0.01% 833
2023
Q4 		$3.11K Hold
50
– – ﹤0.01% 804
2023
Q3 		$2.81K Hold
50
– – ﹤0.01% 805
2023
Q2 		$2.52K Hold
50
– – ﹤0.01% 841
2023
Q1 		$2.73K Hold
50
– – ﹤0.01% 809
2022
Q4 		$3.13K Hold
50
– – ﹤0.01% 805
2022
Q3 		$3.52K Buy
+50
New +$3.45K ﹤0.01% 761

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Glen Eagle Advisors's AXNX Position: Q4 2024 in Review

Glen Eagle Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 50 shares — an estimated $3.48K sold.

Glen Eagle Advisors first reported a position in AXNX in Q3 2022 and held it in 9 quarters. The position peaked at $3.52K in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Glen Eagle Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Glen Eagle Advisors sold 50 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $3.48K.
  • Glen Eagle Advisors first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 9 quarters.
  • Glen Eagle Advisors's Axonics, Inc. Common Stock position peaked at $3.52K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Glen Eagle Advisors's 13F filing for Q4 2024, filed 18 Feb 2025.